Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports.
Mefloquine is a relatively new antimalarial drug which has been associated with a wide variety of adverse effects, including skin reactions. In order to evaluate the range and frequency of mefloquine's dermatological effects, we searched the scientific literature for published case reports of such effects. We found 74 case reports, published between the years 1983 and 1997. Pruritus and maculopapular rash are the dermatological effects most commonly associated with mefloquine: their approximate frequency is 4-10% for pruritus, and up to 30% for nonspecific maculopapular rash. Adverse effects associated less commonly with mefloquine include urticaria, facial lesions and cutaneous vasculitis. One case of Stevens-Johnson syndrome and one fatal case of toxic epidermal necrolysis occurred. Appropriate primary studies of mefloquine use should be carried out to elucidate the epidemiology and aetiology of dermatological and other adverse effects of the drug.
Smith
H R
HR
St. John's Institute of Dermatology, St Thomas' Hospital, London UK.
Croft
A M
AM
Black
M M
MM
D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000009:adverse effects*; D002648:Child; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000209:etiology*; D005076:Exanthema / Q000139:chemically induced; D005148:Facial Dermatoses / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D015767:Mefloquine / Q000009:adverse effects*; D017445:Skin Diseases, Vascular / Q000139:chemically induced; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000209:etiology; D014581:Urticaria / Q000139:chemically induced; D014657:Vasculitis / Q000139:chemically induced
D000962:Antimalarials; D015767:Mefloquine